Professor Z Wang et al. reported that RSK4 could promote the cell cycle process, tumor invasion, and tumor migration of renal cancer cells, and may become a potential new therapeutic target for renal cancer patients [21]. Here, RPS6KA6 is linked to renal carcinoma.